MedPath

Exploring the efficacy of remote stepped care treatment for obsessive-compulsive disorder: A feasibility study.

Not Applicable
Recruiting
Conditions
obsessive compulsive disorder
Mental Health - Anxiety
Mental Health - Other mental health disorders
Registration Number
ACTRN12623000213640
Lead Sponsor
niversity of Technology Sydney
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

(a) English speaking;
(b) Australian resident;
(c) 18 years-of-age or above;
(d) Have regular access to the internet;
(e) No suicidal plans or intention, or recent history of suicide attempts or deliberate self-harm;
(f) A score of at least 16 on the Yale-Brown Obsessive Compulsive Scale (YBOCS);
(g) A score of at least 7 on the Dimensional Obsessive Compulsive Scale (DOCS);
(h) Meet criteria for OCD as primary on the Diagnostic Interview for Anxiety, Mood, Obsessive-Compulsive and other Neuropsychiatric Disorders (DIAMOND).

Exclusion Criteria

None

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
OCD symptom severity assessed using the Yale Brown Obsessive Compulsive Scale[ Pre-treatment<br>Weekly in step 1<br>Mid-treatment (week 5 of step 1)<br>Post step 1 (week 9 post-commencement of intervention)<br>Weekly in step 2<br>Post step 2 (week 17 post-commencement of intervention; primary endpoint)];OCD symptom severity assessed using the Dimensional Obsessive Compulsive Scale[ Pre-treatment<br>Mid-treatment (week 5 of step 1)<br>Post step 1 (week 9 post-commencement of intervention)<br>Post step 2 (week 17 post-commencement of intervention; primary endpoint)];Acceptability will be measured with the Client Satisfaction Questionnaire[ Post step 1 (week 9 post-commencement of intervention)<br>Post step 2 (week 17 post-commencement of intervention; primary endpoint)]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath